FDA continues review of Crofelemer beyond goal date
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Mumbai: The Food and Drug Administration has advised Salix Pharmaceuticals, Mumbai-based Glenmark's collaborative partne...Read more
Biocon clocks revenue worth $121 mn
India | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013
Bangalore: Indian biopharma giant Biocon reported healthy growth of 22 percent for Q1 FY14. The firm clocked revenues wo...Read more
Trivitron JV to lead immunodiagnostics sector in 3 years
India | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012
Bangalore: Trivitron Healthcare entered in a strategic partnership with Diasorin Group, a global leader in $11 billion ...Read more
Sandoz focuses on developing modern drugs for TB'
India | News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2012
Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufac...Read more
What the UK plans to do at Bangalore India BIO?
India | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
A positive business environment, access to global expertise and the presence of world renowned universities, is helping ...Read more
Accuray announces first two CyberKnife systems in India
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Accuray, the premier radiation oncology company, announced that Medanta - The Medicity Cancer Institute, and...Read more
India's new pharma pricing policy will be a profitability challenge: Glenn Saldanha
India | Opinion | By BioSpectrum Bureau | 0 Comment | 20 May, 2013
The Indian pharmaceutical industry has witnessed a healthy growth in the last decade, driven by factors like rising cons...Read more
Asia's challenge: Meeting US, EU requirements
India | Opinion | By BioSpectrum Bureau | 3 Comment | 12 Oct, 2012
One of the biggest challenges in developing and manufacturing antibodies is proving the equivalence or similarity to the...Read more
Cipla acquires 51 percent stake in Yemen
India | News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2014
Singapore: Given the recent preference to local manufacturing, this secures the company's presence in a fast growing mar...Read more
Asia has potential in NGS research: Dr Partha Majumdar
India | Influencers | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2012
Dr Partha Majumder is a principal investigator representing India in the International Cancer Genome Consortium, focussi...Read more
Indian President praises 1Clik diabetes device
India | News | By BioSpectrum Bureau | 0 Comment | 28 Jan, 2013
Mumbai: The Indian President, Mr Pranab Mukherjee, and the Governor of the Indian state of Tripura, Dr D Y Patil, praise...Read more
Boehringer heart drug is particularly effective in Asian population
India | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012
Singapore: Boehringer Ingelheim has reported that in Asian populations, Pradaxa (dabigatran etexilate) offers considerab...Read more
Apollo India to setup proton therapy cancer center
India | News | By BioSpectrum Bureau | 0 Comment | 21 Jan, 2013
Chennai: Apollo Hospitals will establish a Proton Therapy Center in India, the first of its kind across South East Asia...Read more
Biocon insulin study gives positive results
India | Company results | By BioSpectrum Bureau | 4 Comment | 31 Oct, 2012
Bangalore: The global phase III study for Biocon's recombinant human insulin (Insugen(R)), in Type 1 diabetes mellitus p...Read more
India to soon decide on FDI policy in pharma
India | News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2013
Singapore: Ahead of the raging issue of Foreign Direct Investment (FDI) in the pharmaceutical sector in India, the count...Read more
Biocon's earnings surge in Q1 FY16
India | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2015
Biocon announced that it has delivered a strong consolidated financial performance for Q1 FY16. Commenting on the quart...Read more
India's H1N1 vaccine demand to grow by 2.1%
India | News | By BioSpectrum Bureau | 0 Comment | 09 Jan, 2013
Singapore: Business intelligence provider GlobalData estimates that India is expected to exhibit a great surge in H1N1 ...Read more
Pain killer from Venus Remedies gets BioSpectrum award
India | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2012
Aceclofenac injection, launched under the brandname of Achnil, by Venues Remedies is a non-steroidal anti-inflammatory ...Read more